Over the last year, digital has transformed the caregiver experience, but pharma has also been undergoing a metamorphosis in order to reach patients.
During the pandemic, life science companies were pushed to reconfigure their care in order to meet the needs of some of the most at-risk patients. MobiHealthNews sat down with the leader of pharma giant Otsuka's Global Clinical Development on...
Dr. Amy Abernethy, Principal Deputy Commissioner and Acting Chief Information Officer at the FDA, will be stepping down from her positions at the agency in mid-to-late April, according to a memo Acting FDA Commissioner Dr. Janet Woodcock sent out to agency staff this morning.
Abernethy came to the agency in early 2019 following a long line of executive and board positions at healthcare and health...
The history of pharma and provider partnerships spans back decades, and has traditionally focused on the development of new drugs. Digital is coming into the fold of health, forcing those partnerships to go through a metamorphosis to include new tech.
“Industry and academia have been working together for decades in a pharmaceutical sector, but historically the relationships did not extend beyond...
AI isn't ready for COVID-19 prime time. A systematic review of published this week in nature machine intelligence warns that new models using machine learning to review chest radiographs and chest computed tomographies for COVID-19 have major methodical deficiencies or underlying biases.
Among the 62 published or pre-print papers outlining these approaches, the authors wrote that not a single one...
IMA Clinical Research, a division of the IMA Group that provides clinical evaluation and research services, has partnered with AiCure to deploy the patient engagement company's Patient Connect tool to patients in a new effort to observe health management beyond the traditional study setting.
The 30-day program will have participants using the smartphone app to confirm adherent dosing behavior and...
Diabetes management company Welldoc is teaming up with Eli Lilly on a new licensing and collaboration agreement that promises to integrate the former’s software into the pharma company’s insulin products, which are still in the pipeline.
The partners plan on creating a new version of Welldoc’s BlueStar, an app-based diabetes management platform that will be able to integrate insulin dosing data...
It’s no secret that Click Therapeutics is on a roll with pharma partnerships. The mental health-focused digital therapeutic company made headlines this week when it announced a new clinical trial with Japanese pharma company Otsuka, based on a deal made in 2019.
But this isn't the only deal the New York-based company worked on with the life science industry. In September, the company signed a $...
All around the world the coronavirus pandemic has led to an uptick in digital healthcare delivery models. While telemedicine is often touted as the poster child of digital success in 2020, digital therapeutics (DTx) also emerged as a player on the global stage.
"What we are seeing is digital therapeutics, while they won’t directly treat COVID, they are really an integral component of this...
Otsuka Pharmaceutical and Click Therapeutics have announced the launch of a new, fully remote clinical trial being conducted on Verily's Project Baseline platform.
Called the Mirai study, it will be measuring a digital therapeutics intervention's effectiveness in reducing symptoms of depression among adults who have a major depressive disorder (MDD) diagnosis and are on antidepressant monotherapy...
Pharma giant AstraZeneca is teaming up with AliveCor, maker of artificial intelligence-enabled personal ECG devices, in an effort to study new ways of managing cardio, renal and metabolic issues.
The partnership will revolve around AliveCor’s Kardia-K AI, which is designed to analyze ECGs in order to measure a patient’s potassium levels without needing to draw blood from the patient. Specifically...
.jpg?itok=n4N5nDjy)
